NAKI Therapeutics will be presenting at the upcoming BIO International Convention (June 13-16, 2022・San Diego Convention Center)

Board of Directors

Guanghui Hu, PhD

Chief Executive Officer

Read More

Don Liu, PhD

Board Member / CSO

Read More

David Xu

Board Member

Read More

ABOUT US

Company Overview
Management Team
Board of Directors
Scientific Advisory Board

SCIENCE

CD147
Expansion Technology
Oncology / HCC

PUBLICATIONS

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells
Efficacy of anti-CD147

CONTACT US